Changes carbohydrate lipid metabolism children asthma budesonide longitudinal study antiasthmatic metabolic effects budesonide inhalations high month months dosage children asthma years high dosage median dosage baseline Clinically additional weeks treatment Serum high-density lipoprotein cholesterol high dosage medians versus mmol/L significant decline mmol/L dose overall treatment significant effect serum total cholesterol serum triglycerides ratio high-density lipoprotein total cholesterol body mass index glucose tolerance high dosage ratio serum insulin blood glucose areas incremental curves glucose tolerance test medians versus mU/mmol dosage ratio mU/mmol overall significant changes plasma cortisol adrenocorticotropic hormone test antiasthmatic effect budesonide inhalations dose month detectable changes lipid carbohydrate metabolism metabolic changes reversible antiasthmatic effect dose months significant systemic effects dose safe efficient maintenance treatment childhood asthma 